NEW YORK — Genetic variants contribute to the increased risk of treatment-linked heart problems among pediatric cancer survivors of African ancestry, a new study has found.
Children who have survived cancer are at increased risk of cardiomyopathy, particularly if they were treated with anthracycline chemotherapy or radiation therapy that involved the heart. But most analyses have relied on children of European ancestry.